Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous stromal vascular fraction for refractory diabetic foot ulcers
2021-002043-30Phase 2Active
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- May 2021
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, single-arm trial of autologous stromal vascular fraction of adipose tissue in diabetic foot ulcer (DFU), sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Complete wound healing at week 20. Started May 2021; status: active.
02
Drugs
autologous stromal vascular fraction of adipose tissue
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on 2021-002043-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002043-30.